Traditional Septoplasty Vs Endoscopic Septoplasty for Treating Deviated Nasal Septum
Traditional Septoplasty Vs Endoscopic Septoplasty for Treating Deviated Nasal Septum: A Prospective, Randomized Controlled Trial
In this study the investigators aim to assess whether endoscopic septoplasty is effective at improving patients QOL and reducing postoperative signs and complications.
Primary outcome: To assess the differences in overall QOL between endoscopic and traditional septoplasty after adjusting for pertinent confounding variables.
Secondary outcomes:
- To evaluate the post-operative complication rate in patients undergoing endoscopic septoplasty compared to traditional.
- To evaluate the differences in the operation time between the two different approaches.
Aperçu de l'étude
Statut
Les conditions
Intervention / Traitement
Description détaillée
Nasal obstruction is one of the most common complaints that the otorhinolaryngologist faces in the daily practice. Deviated nasal septum (DNS) is a very frequently encountered and common cause. It not only causes breathing difficulties but also results in improper aeration of paranasal sinuses predisiposing to sinusitis and also results in drying of mucosa leading to crusting and epistaxis 1,2. DNS can also be accompanied with hypertrophic nasal turbinates causing sleep disturbances and snoring3.
Septoplasty is an accepted and common surgical intervention to improve the nasal airway4 and sleep disturbances3.
Traditional septoplasty procedure involves sum mucosal resection of the anterior septum. The results for long-term symptom relief after traditional septoplasty are contradictory in reviewed publications 5.
In the last two decades the endoscopic Sino nasal surgery has been widely used including endoscopic approach for septoplasty. Endoscopic septoplasty as a minimally invasive technique where the dissection of the nasal septal flap can be limited minimizing trauma. The excellent visualization is presumed to decrease morbidity and post-operative swelling in isolated septal deviation by limiting the excision to the area of deviation 2. Furthermore, diagnosing and treating abnormalities of the lateral wall of the nose at the same sitting is only feasible in the endoscopic approach.
At the time of this study, there are no studies comparing the changes of quality of life in patients undergoing traditional septoplasty Vs endoscopic septoplasty.
The investigators aimed to assess whether endoscopic septoplasty is effective at improving patients QOL and reducing postoperative signs and complications.
Aims
Primary:
1) To assess the differences in overall QOL between endoscopic and traditional septoplasty after adjusting for pertinent confounding variables.
Secondary:
- To evaluate the post-operative complication rate in patients undergoing endoscopic septoplasty compared to traditional.
- To evaluate the differences in the operation time between the two different approaches.
Type d'étude
Inscription (Anticipé)
Phase
- N'est pas applicable
Contacts et emplacements
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
Accepte les volontaires sains
Sexes éligibles pour l'étude
La description
Inclusion Criteria:
- Diagnosis of nasal obstruction and deviated nasal septum with or without hypertrophy of nasal turbinates.
- Patient undergoing surgery for repairing the deviated nasal septum.
Exclusion Criteria:
- Diagnosis of bilateral acute or chronic rhinosinusitis or nasal polyposis
- Patients undergoing endoscopic sinonasal surgery.
- Diagnosed with inflammatory (e.g. Wegener's granulomatosis, sarcoidosis) or neoplastic nasal pathology
- Diagnosed with systemic conditions affecting the nose e.g. Cystic fibrosis, Kartagener's syndrome
- Patients listed for revision surgery
- Neoplasms - untreated or under active or recent treatment with chemotherapy or radiotherapy
- Unable to give informed consent due to mental impairment
- Unable to adhere follow up or treatment.
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
- Objectif principal: Traitement
- Répartition: Randomisé
- Modèle interventionnel: Affectation parallèle
- Masquage: Seul
Armes et Interventions
Groupe de participants / Bras |
Intervention / Traitement |
|---|---|
|
Comparateur actif: Traditional
a control arm of patients undergoing traditional septoplasty for DNS
|
septoplasty under direct vision
|
|
Expérimental: Endoscopic
patients undergoing endoscopic septoplasty.
|
Endoscopic surgery; septoplasty with or without middle turbenectomy
|
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Change in Quality of life
Délai: Baseline (maximum 3 months before surgery), at 2-3 weeks, and 3-4 months after the surgery.
|
quality of life will assessed using Sino-Nasal Outcome Test-22 (SNOT-22) scores.
|
Baseline (maximum 3 months before surgery), at 2-3 weeks, and 3-4 months after the surgery.
|
Collaborateurs et enquêteurs
Parrainer
Publications et liens utiles
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude
Achèvement primaire (Anticipé)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Estimation)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Estimation)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Autres numéros d'identification d'étude
- 0576-15-RMB
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .
Essais cliniques sur Intranasal Surgery
-
Columbia UniversityRésiliéLa douleur | Évaluation de la pharmacocinétique du kétorolac intranasalÉtats-Unis
-
Egalet LtdComplétéÉvaluer la pharmacocinétique du kétorolac trométhamine intranasal et évaluer les effets d'un chlorhydrate d'oxymétazoline sur la pharmacocinétique du kétorolac trométhamineRoyaume-Uni